A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests - ...

New breast cancer drug vepdegestrant shows promising results in increasing survival rates for patients with ESR1 mutations.

Dutch authorities say there is currently no evidence that children in the Netherlands were conceived using sperm from a donor ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Rare cancer gene TP53 found in 23 out of 67 donor-conceived children * 10 children have already developed cancer, including ...

A rare genetic mutation in a European sperm donor has reportedly caused cancer in 10 children, highlighting the need for ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

A new drug combination has been shown to double survival time for patients with a particularly aggressive type of colorectal ...

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...